1. Home
  2. CODA vs CTOR Comparison

CODA vs CTOR Comparison

Compare CODA & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • CTOR
  • Stock Information
  • Founded
  • CODA 1994
  • CTOR 2021
  • Country
  • CODA United States
  • CTOR United States
  • Employees
  • CODA N/A
  • CTOR N/A
  • Industry
  • CODA Industrial Machinery/Components
  • CTOR
  • Sector
  • CODA Industrials
  • CTOR
  • Exchange
  • CODA Nasdaq
  • CTOR NYSE
  • Market Cap
  • CODA 92.5M
  • CTOR 89.9M
  • IPO Year
  • CODA N/A
  • CTOR N/A
  • Fundamental
  • Price
  • CODA $6.05
  • CTOR $0.80
  • Analyst Decision
  • CODA Strong Buy
  • CTOR Strong Buy
  • Analyst Count
  • CODA 1
  • CTOR 2
  • Target Price
  • CODA $11.00
  • CTOR $4.50
  • AVG Volume (30 Days)
  • CODA 16.8K
  • CTOR 91.8K
  • Earning Date
  • CODA 03-17-2025
  • CTOR 05-21-2025
  • Dividend Yield
  • CODA N/A
  • CTOR N/A
  • EPS Growth
  • CODA 61.24
  • CTOR N/A
  • EPS
  • CODA 0.34
  • CTOR N/A
  • Revenue
  • CODA $21,064,685.00
  • CTOR N/A
  • Revenue This Year
  • CODA $31.72
  • CTOR N/A
  • Revenue Next Year
  • CODA $12.23
  • CTOR N/A
  • P/E Ratio
  • CODA $18.74
  • CTOR N/A
  • Revenue Growth
  • CODA 15.63
  • CTOR N/A
  • 52 Week Low
  • CODA $5.66
  • CTOR $0.55
  • 52 Week High
  • CODA $9.89
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • CODA 21.72
  • CTOR N/A
  • Support Level
  • CODA $6.53
  • CTOR N/A
  • Resistance Level
  • CODA $7.11
  • CTOR N/A
  • Average True Range (ATR)
  • CODA 0.44
  • CTOR 0.00
  • MACD
  • CODA -0.03
  • CTOR 0.00
  • Stochastic Oscillator
  • CODA 2.84
  • CTOR 0.00

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: